Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 688 | 1,091 | 884 | 289 | 567 |
| Gross Profit | 688 | 1,091 | 884 | 289 | 567 |
| Operating Expenses | 10,440 | 6,656 | 7,901 | 11,999 | 12,719 |
| Operating Income | -9,752 | -5,565 | -7,017 | -11,710 | -12,152 |
| Interest Expense | 226 | 120 | 141 | 66 | 61 |
| Other Income | 44 | 152 | 1,018 | 301 | 357 |
| Pre-tax Income | -9,934 | -5,533 | -6,140 | -11,475 | -11,856 |
| Income Tax | -6 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -9,928 | -5,533 | -6,140 | -11,475 | -11,856 |
| Net Income | $-9,928 | $-5,533 | $-6,140 | $-11,475 | $-11,856 |
| EPS Basic Total Ops | -0.53 | -0.30 | -0.32 | -0.62 | -0.64 |
| EPS Basic Continuous Ops | -0.53 | -0.30 | -0.32 | -0.62 | -0.64 |
| EPS Diluted Total Ops | -0.53 | -0.30 | -0.32 | -0.62 | -0.64 |
| EPS Diluted Continuous Ops | -0.53 | -0.30 | -0.32 | -0.62 | -0.64 |
| EBITDA(a) | $-9,625 | $-5,471 | $-6,979 | $-11,684 | $-12,281 |